Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Health Catalyst, Inc. before investing.

In this article, we go over a few key elements for understanding Health Catalyst, Inc.’s stock price such as:

• Health Catalyst, Inc.’s current stock price and volume
• Why Health Catalyst, Inc.’s stock price changed recently
• Upgrades and downgrades for HCAT from analysts
• HCAT’s stock price momentum as measured by its relative strength

About Health Catalyst, Inc. (HCAT)

Before we jump into Health Catalyst, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, accountable care organizations, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

Want to learn more about Health Catalyst, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Health Catalyst, Inc..

Health Catalyst, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Health Catalyst, Inc.’s stock price was $2.090.

Health Catalyst, Inc. is up 0.48% from its previous closing price of $2.080.

During the last market session, Health Catalyst, Inc.’s stock traded between $2.045 and $2.120. Currently, there are approximately 72.59 million shares outstanding for Health Catalyst, Inc..

Health Catalyst, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Health Catalyst, Inc. Stock Price History

Health Catalyst, Inc.’s (HCAT) price is currently up 5.03% so far this month.

During the month of July, Health Catalyst, Inc.’s stock price has reached a high of $2.390 and a low of $1.980.

Over the last year, Health Catalyst, Inc. has hit prices as high as $3.880 and as low as $0.955. Year to date, Health Catalyst, Inc.’s stock is down 12.55%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Health Catalyst, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were 0 analysts who downgraded Health Catalyst, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Health Catalyst, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Health Catalyst, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Health Catalyst, Inc.’s current valuation based on AAII’s Value Grade is a B, which means it is considered to be Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Health Catalyst, Inc. (HCAT) by visiting AAII Stock Evaluator.

Relative Price Strength of Health Catalyst, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Health Catalyst, Inc. has a weighted four-quarter relative price strength of -1.80%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how Health Catalyst, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Health Catalyst, Inc. Stock Price: Bottom Line

As of July 31, 2026, Health Catalyst, Inc.’s stock price is $2.090, which is up 0.48% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Health Catalyst, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.